Strongbridge Biopharma plc. (SBBP) NASDAQ

$2.13 0.07 (3.40%)

Market Cap: $144.48M

As of 09/24/21 04:00 PM EDT. Market closed.

(SBBP)

Strongbridge Biopharma plc. (SBBP) NASDAQ

$2.13 0.07 (3.40%)

Market Cap: $144.48M

As of 09/24/21 04:00 PM EDT. Market closed.

Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Strongbridge's rare endocrine franchise includes RECORLEV® (levoketoconazole), a cortisol synthesis inhibitor currently being studied in Phase 3 clinical studies for the treatment of endogenous Cushing's ... read more

Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Strongbridge's rare endocrine franchise includes RECORLEV® (levoketoconazole), a cortisol synthesis inhibitor currently being studied in Phase 3 clinical studies for the treatment of endogenous Cushing's syndrome, and veldoreotide extended release, a preclinical next-generation somatostatin analog being investigated for the treatment of acromegaly and potential additional applications in other conditions amenable to somatostatin receptor activation. Both RECORLEV and veldoreotide have received orphan drug designation from the FDA and the European Medicines Agency. The Company's rare neuromuscular franchise includes KEVEYIS® (dichlorphenamide), the first and only FDA-approved treatment for hyperkalemic, hypokalemic, and related variants of primary periodic paralysis. KEVEYIS has orphan drug exclusivity in the United States. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Matthew Pauls
Full Time Employees
72
CEO Compensation (Base)
$540,000
CEO Compensation (Total)
$2.65M
URL
Address
900 Northbrook Dr Ste 200, Pennsylvania, Trevose, 19053-8433.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Matthew Pauls
Full Time Employees
72
CEO Compensation (Base)
$540,000
CEO Compensation (Total)
$2.65M
Address
900 Northbrook Dr Ste 200, Pennsylvania, Trevose, 19053-8433.
KEY STATS
Open
$2.07
Previous Close
$2.06
Days Range
$2.02 - $2.15
52 week range
$1.85 - $4.26
Volume
76,472
Avg. Volume (30 days)
252,583
Market Cap
$144.48M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
67,828,952
Open
$2.07
Previous Close
$2.06
Days Range
$2.02 - $2.15
52 week range
$1.85 - $4.26
Volume
76,472
Avg. Volume (30 days)
252,583
Market Cap
$144.48M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
67,828,952

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR STRONGBRIDGE BIOPHARMA PLC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Kollender Richard S President and CFO Sep 03, 2021 Option Exercise $2.24 17,088 38,277 299,020 Sep 08, 2021, 04:42 PM
JOHNSON JOHN Chief Executive Officer Jul 02, 2021 Option Exercise $3.08 50,867 156,670 944,960 Jul 07, 2021, 05:01 PM
Kong Garheng Director May 14, 2021 Option Exercise $2.35 19,200 45,120 41,756 May 17, 2021, 07:27 PM
Steineger Hilde H Director May 14, 2021 Option Exercise $2.35 18,944 44,518 42,021 May 17, 2021, 06:33 PM
SHERMAN JEFFREY W Director May 14, 2021 Option Exercise $2.35 18,944 44,518 42,021 May 17, 2021, 06:31 PM
JOHNSON JOHN Chief Executive Officer Apr 08, 2021 Option Exercise $2.68 17,325 46,431 995,827 Apr 09, 2021, 05:13 PM
Wilhoit Scott L. Chief Commercial Officer Feb 22, 2021 Option Exercise $3.62 7,121 25,778 137,025 Feb 23, 2021, 05:16 PM
Lutz Robert Matthew Chief Financial Officer Feb 22, 2021 Option Exercise $3.62 6,978 25,260 181,333 Feb 23, 2021, 05:16 PM
LONG STEPHEN J Chief Legal Officer Feb 22, 2021 Option Exercise $3.62 7,062 25,564 167,100 Feb 23, 2021, 05:15 PM
Cohen Fredric J. Chief Medical Officer Feb 22, 2021 Option Exercise $3.62 6,978 25,260 211,956 Feb 23, 2021, 05:14 PM
GILL DAVID N Director Sep 24, 2020 Buy $2.13 8,000 17,040 74,896 Sep 28, 2020, 07:48 AM
CDK ASSOCIATES, L.L.C. 10% Owner Sep 18, 2020 Buy $2.20 6,000 13,200 8,060,682 Sep 21, 2020, 09:48 PM
CDK ASSOCIATES, L.L.C. 10% Owner Sep 17, 2020 Buy $2.25 1,473,377 3,315,098 8,054,682 Sep 21, 2020, 09:48 PM
GILL DAVID N Director Sep 03, 2020 Option Exercise $3.61 23,104 83,405 66,896 Sep 04, 2020, 04:28 PM
Steineger Hilde H Director May 15, 2020 Option Exercise $2.86 19,035 54,440 60,965 May 18, 2020, 04:52 PM
Steen Marten Director May 15, 2020 Option Exercise $2.86 19,082 54,575 60,918 May 18, 2020, 04:52 PM
SHERMAN JEFFREY W Director May 15, 2020 Option Exercise $2.86 19,035 54,440 60,965 May 18, 2020, 04:51 PM
Kong Garheng Director May 15, 2020 Option Exercise $2.86 19,044 54,466 60,956 May 18, 2020, 04:51 PM
JOHNSON JOHN Executive Chairman May 15, 2020 Option Exercise $2.86 15,348 43,895 207,152 May 18, 2020, 04:51 PM
CDK ASSOCIATES, L.L.C. 10% Owner Dec 27, 2018 Buy $3.98 18,200 72,434 6,581,305 Dec 28, 2018, 05:39 PM
CDK ASSOCIATES, L.L.C. 10% Owner Dec 26, 2018 Buy $4.00 31,197 124,698 6,563,105 Dec 28, 2018, 05:39 PM
CDK ASSOCIATES, L.L.C. 10% Owner Dec 21, 2018 Buy $3.95 90,612 357,990 6,531,908 Dec 21, 2018, 06:16 PM
CDK ASSOCIATES, L.L.C. 10% Owner Dec 20, 2018 Buy $4.00 146,467 585,385 6,441,296 Dec 21, 2018, 06:16 PM
Cohen Fredric J. Chief Medical Officer Nov 23, 2018 Option Exercise $5.21 1,740 9,065 13,434 Nov 26, 2018, 04:44 PM
CDK ASSOCIATES, L.L.C. 10% Owner Aug 08, 2018 Buy $4.93 360,995 1,778,514 6,294,829 Aug 09, 2018, 12:28 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 30, 2018 Buy $4.66 70,000 326,466 5,933,834 Aug 01, 2018, 04:56 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 26, 2018 Buy $4.94 39,800 196,727 5,654,534 Jul 27, 2018, 06:15 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 24, 2018 Buy $4.92 150,000 737,265 5,614,734 Jul 27, 2018, 06:15 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 27, 2018 Buy $4.73 209,300 989,188 5,863,384 Jul 27, 2018, 06:15 PM
Cohen Fredric J. Chief Medical Officer Jun 13, 2018 Option Exercise $6.30 2,174 13,696 15,174 Jul 25, 2018, 03:37 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 20, 2018 Buy $4.97 21,100 104,795 5,444,334 Jul 23, 2018, 05:33 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 19, 2018 Buy $4.98 14,000 69,747 5,423,234 Jul 23, 2018, 05:33 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 23, 2018 Buy $4.95 20,400 100,980 5,464,734 Jul 23, 2018, 05:33 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 16, 2018 Buy $4.97 11,200 55,629 5,409,234 Jul 18, 2018, 01:55 PM
LONG STEPHEN J Chief Legal Officer Feb 26, 2018 Option Exercise $6.60 9,056 59,770 10,662 Feb 28, 2018, 02:37 PM
Pauls Matthew President & CEO Feb 26, 2018 Option Exercise $6.60 17,392 114,787 22,608 Feb 28, 2018, 02:37 PM
Cohen Fredric J. Chief Medical Officer Feb 26, 2018 Option Exercise $6.60 5,652 37,303 17,348 Feb 28, 2018, 02:37 PM
DAVIS A BRIAN Chief Financial Officer Feb 26, 2018 Option Exercise $6.60 8,696 57,394 13,366 Feb 28, 2018, 02:37 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Kollender Richard S President and CFO 09/03/2021 38,277
JOHNSON JOHN Chief Executive Officer 07/02/2021 156,670
Kong Garheng Director 05/14/2021 45,120
Steineger Hilde H Director 05/14/2021 44,518
SHERMAN JEFFREY W Director 05/14/2021 44,518
JOHNSON JOHN Chief Executive Officer 04/08/2021 46,431
Wilhoit Scott L. Chief Commercial Officer 02/22/2021 25,778
Lutz Robert Matthew Chief Financial Officer 02/22/2021 25,260
LONG STEPHEN J Chief Legal Officer 02/22/2021 25,564
Cohen Fredric J. Chief Medical Officer 02/22/2021 25,260
GILL DAVID N Director 09/24/2020 17,040
CDK ASSOCIATES, L.L.C. 10% Owner 09/18/2020 13,200
CDK ASSOCIATES, L.L.C. 10% Owner 09/17/2020 3,315,098
GILL DAVID N Director 09/03/2020 83,405
Steineger Hilde H Director 05/15/2020 54,440
Steen Marten Director 05/15/2020 54,575
SHERMAN JEFFREY W Director 05/15/2020 54,440
Kong Garheng Director 05/15/2020 54,466
JOHNSON JOHN Executive Chairman 05/15/2020 43,895
CDK ASSOCIATES, L.L.C. 10% Owner 12/27/2018 72,434
CDK ASSOCIATES, L.L.C. 10% Owner 12/26/2018 124,698
CDK ASSOCIATES, L.L.C. 10% Owner 12/21/2018 357,990
CDK ASSOCIATES, L.L.C. 10% Owner 12/20/2018 585,385
Cohen Fredric J. Chief Medical Officer 11/23/2018 9,065
CDK ASSOCIATES, L.L.C. 10% Owner 08/08/2018 1,778,514
CDK ASSOCIATES, L.L.C. 10% Owner 07/30/2018 326,466
CDK ASSOCIATES, L.L.C. 10% Owner 07/26/2018 196,727
CDK ASSOCIATES, L.L.C. 10% Owner 07/24/2018 737,265
CDK ASSOCIATES, L.L.C. 10% Owner 07/27/2018 989,188
Cohen Fredric J. Chief Medical Officer 06/13/2018 13,696
CDK ASSOCIATES, L.L.C. 10% Owner 07/20/2018 104,795
CDK ASSOCIATES, L.L.C. 10% Owner 07/19/2018 69,747
CDK ASSOCIATES, L.L.C. 10% Owner 07/23/2018 100,980
CDK ASSOCIATES, L.L.C. 10% Owner 07/16/2018 55,629
LONG STEPHEN J Chief Legal Officer 02/26/2018 59,770
Pauls Matthew President & CEO 02/26/2018 114,787
Cohen Fredric J. Chief Medical Officer 02/26/2018 37,303
DAVIS A BRIAN Chief Financial Officer 02/26/2018 57,394
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2021
12/31/2020
16.21%
1Q
03/31/2021
09/30/2020
22.76%
2Q
03/31/2021
06/30/2020
24.16%
3Q
03/31/2021
03/31/2020
23.75%
4Q
03/31/2021
12/31/2019
21.65%
5Q
03/31/2021
09/30/2019
20.65%
6Q
03/31/2021
06/30/2019
19.75%
7Q
03/31/2021
03/31/2019
24.41%
8Q
03/31/2021
12/31/2018
35.50%
9Q
03/31/2021
09/30/2018
34.79%
10Q
03/31/2021
06/30/2018
33.78%
11Q
Load More

Period of Report: 03/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2020
16.21%
1Q
09/30/2020
22.76%
2Q
06/30/2020
24.16%
3Q
03/31/2020
23.75%
4Q
12/31/2019
21.65%
5Q
09/30/2019
20.65%
6Q
06/30/2019
19.75%
7Q
03/31/2019
24.41%
8Q
12/31/2018
35.50%
9Q
09/30/2018
34.79%
10Q
06/30/2018
33.78%
11Q
Load More